3 Biotechs That Have Doubled Investors' Money in Less Than a Year Post author:Sam Post published:January 22, 2018 Post category:BioPharma Having a stock double in value is a good thing. Source: BioSpace You Might Also Like Adaptimmune Sees Positive Early Results in Cancer Treatment March 15, 2018 Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease August 2, 2017 Show Me The Money: Bay Area???s Top 5 Venture Capital-Backed Biotechs September 14, 2017
Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease August 2, 2017
